NO971621L - Keratinocyttvekstfaktoranaloger - Google Patents

Keratinocyttvekstfaktoranaloger

Info

Publication number: NO971621L
Authority: NO; Norway
Prior art keywords: kgf; analogs; keratinocyttvekstfaktoranaloger; deletion; seq
Prior art date: 1994-10-13

Application number

NO971621A

Other languages

English (en)

Norwegian (no)

Other versions

NO971621D0 (no

Inventor

Bao-Lu Chen

Tsutomu Arakawa

Original Assignee

Amgen Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-10-13

Filing date

1997-04-09

Publication date

1997-06-12

1997-04-09 Application filed by Amgen Inc filed Critical Amgen Inc

1997-04-09 Publication of NO971621D0 publication Critical patent/NO971621D0/no

1997-06-12 Publication of NO971621L publication Critical patent/NO971621L/no

Links

125000000539 amino acid group Chemical group 0.000 abstract 1
150000001413 amino acids Chemical class 0.000 abstract 1
230000037430 deletion Effects 0.000 abstract 1
238000012217 deletion Methods 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
238000006467 substitution reaction Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Diabetes (AREA)
Dermatology (AREA)
Gastroenterology & Hepatology (AREA)
Hematology (AREA)
Molecular Biology (AREA)
Ophthalmology & Optometry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Toxicology (AREA)
Zoology (AREA)
Endocrinology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Obesity (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Emergency Medicine (AREA)
Pulmonology (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO971621A 1994-10-13 1997-04-09 Keratinocyttvekstfaktoranaloger NO971621L (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US32333794A	1994-10-13	1994-10-13
US48782595A	1995-06-07	1995-06-07
PCT/US1995/013075 WO1996011951A2 (en)	1994-10-13	1995-10-12	Keratinocyte growth factor analogs

Publications (2)

Publication Number	Publication Date
NO971621D0 NO971621D0 (no)	1997-04-09
NO971621L true NO971621L (no)	1997-06-12

Family

ID=26983900

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO971621A NO971621L (no)	1994-10-13	1997-04-09	Keratinocyttvekstfaktoranaloger

Country Status (14)

Country	Link
EP (1)	EP0785950B1 (ja)
JP (2)	JP4422210B2 (ja)
AT (1)	ATE237634T1 (ja)
AU (1)	AU3893195A (ja)
CA (1)	CA2202390C (ja)
DE (1)	DE69530404T2 (ja)
DK (1)	DK0785950T3 (ja)
ES (1)	ES2196088T3 (ja)
HU (1)	HUT78069A (ja)
MX (1)	MX9702665A (ja)
NO (1)	NO971621L (ja)
PT (1)	PT785950E (ja)
SI (1)	SI0785950T1 (ja)
WO (1)	WO1996011951A2 (ja)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7084119B2 (en)	1993-06-29	2006-08-01	Chiron Corporation	Truncated keratinocyte growth factor (KGF) having increased biological activity
BR9407035A (pt)	1993-06-29	1996-03-12	Chiron Corp	Fragmento de fator de crescimento de queratinócitos conjugado composição terapêutica molécula de DNA vetor de expressão célula hospedeira processo para produzir fragmento de fator de crescimento de queratinócitos processo para cicatrização de ferimento e processo de tratamento de doença hiperproliferativa da epiderme
SI0785949T1 (en) *	1994-10-13	2003-08-31	Amgen Inc.	Method for purifying keratinocyte growth factors
US7232667B2 (en)	1995-02-14	2007-06-19	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 polynucleotides
US6077692A (en)	1995-02-14	2000-06-20	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
US6693077B1 (en)	1995-02-14	2004-02-17	Human Genome Sciences, Inc.	Keratinocyte growth factor-2
AU720232B2 (en)	1996-07-19	2000-05-25	Amgen, Inc.	Analogs of cationic proteins
US6743422B1 (en)	1996-10-15	2004-06-01	Amgen, Inc.	Keratinocyte growth factor-2 products
EP1473366A1 (en) *	1996-10-15	2004-11-03	Amgen Inc.	Keratinocyte growth factor-2 products
DK0935652T3 (da) *	1996-10-15	2004-07-26	Amgen Inc	Keratinocyt vækstfaktor-2 produkter
US6869927B1 (en)	1997-12-22	2005-03-22	Human Genome Sciences, Inc.	Keratinocyte growth factor-2 formulations
KR20010033484A (ko)	1997-12-22	2001-04-25	휴먼 게놈 사이언시즈, 인크.	각질세포 성장 인자-2 제제
US6248725B1 (en)	1999-02-23	2001-06-19	Amgen, Inc.	Combinations and methods for promoting in vivo liver cell proliferation and enhancing in vivo liver-directed gene transduction
JP2005500390A (ja)	2001-08-21	2005-01-06	カイロンコーポレイション	Ｋｇｆポリペプチド組成物
CA2589889C (en)	2004-12-15	2013-07-30	Amgen Inc.	Therapeutic formulations of keratinocyte growth factor
KR20230127721A (ko)	2022-02-25	2023-09-01	한국해양과학기술원	온도안정성을 향상시킨 fgf7 폴리펩타이드 및 그 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GEP20022681B (en) *	1989-01-31	2002-04-25	Aaronson Us Stuart A	Protein KFG, Antibodies, Pharmaceutical Composition, Their Use, recombinant DNA, Cell, Method for Discoveries and Production of Proteins, Method for Stimulation of Epithelial Cells Growth
EP0730651B1 (en) *	1993-09-24	2005-07-06	Wyeth Holdings Corporation	Surface loop structural analogues of fibroblast growth factors

1995
- 1995-10-12 MX MX9702665A patent/MX9702665A/es not_active IP Right Cessation
- 1995-10-12 WO PCT/US1995/013075 patent/WO1996011951A2/en not_active Ceased
- 1995-10-12 CA CA002202390A patent/CA2202390C/en not_active Expired - Fee Related
- 1995-10-12 HU HU9901325A patent/HUT78069A/hu unknown
- 1995-10-12 EP EP95938216A patent/EP0785950B1/en not_active Expired - Lifetime
- 1995-10-12 DK DK95938216T patent/DK0785950T3/da active
- 1995-10-12 ES ES95938216T patent/ES2196088T3/es not_active Expired - Lifetime
- 1995-10-12 SI SI9530653T patent/SI0785950T1/xx unknown
- 1995-10-12 AU AU38931/95A patent/AU3893195A/en not_active Abandoned
- 1995-10-12 PT PT95938216T patent/PT785950E/pt unknown
- 1995-10-12 DE DE69530404T patent/DE69530404T2/de not_active Expired - Lifetime
- 1995-10-12 AT AT95938216T patent/ATE237634T1/de active
- 1995-10-12 JP JP51337096A patent/JP4422210B2/ja not_active Expired - Fee Related
1997
- 1997-04-09 NO NO971621A patent/NO971621L/no unknown
2006
- 2006-09-01 JP JP2006237876A patent/JP2007020575A/ja active Pending

Also Published As

Publication number	Publication date
EP0785950A2 (en)	1997-07-30
DE69530404D1 (de)	2003-05-22
CA2202390C (en)	2005-05-17
ES2196088T3 (es)	2003-12-16
AU3893195A (en)	1996-05-06
NO971621D0 (no)	1997-04-09
HUT78069A (hu)	1999-08-30
ATE237634T1 (de)	2003-05-15
CA2202390A1 (en)	1996-04-25
JP4422210B2 (ja)	2010-02-24
JP2007020575A (ja)	2007-02-01
SI0785950T1 (en)	2003-08-31
PT785950E (pt)	2003-09-30
EP0785950B1 (en)	2003-04-16
DK0785950T3 (da)	2003-07-28
MX9702665A (es)	1997-07-31
WO1996011951A3 (en)	1996-12-12
DE69530404T2 (de)	2003-11-13
WO1996011951A2 (en)	1996-04-25
JP2000511762A (ja)	2000-09-12

Publication	Publication Date	Title
NO971621D0 (no)	1997-04-09	Keratinocyttvekstfaktoranaloger
AU7550098A (en)	1998-12-30	System for expressing hyperthermostable protein
ATE81779T1 (de)	1992-11-15	Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
DE69032600D1 (de)	1998-10-01	Rekombinanter abkömmling des menschlichen faktors iii
SE8901687D0 (sv)	1989-05-11	Fibronectin binding protein as well as its preparation
WO1996011949A3 (en)	1996-12-12	Analogs of keratinocyte growth factor
DK0585285T3 (da)	1999-05-10	Stabiliserede enzymer
RU94045952A (ru)	1996-10-10	Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена
DE69029377D1 (de)	1997-01-23	Substituierungsanaloge von magaininpeptiden
DK1908772T3 (da)	2012-03-19	Polypeptider og polynucleinsyrer af phorphorymonas gingivalis
FI930626A0 (fi)	1993-02-12	Proteinstruktur hos vaexttoxingelonin
ATE242202T1 (de)	2003-06-15	Peptide
PT635025E (pt)	2003-03-31	Processo para preparar proteinas modificadas
CA2201944A1 (en)	1996-07-25	Analogs of keratinocyte growth factor having enhanced temperature stability
EP0330700A4 (en)	1990-01-08	Human prourokinase-like polypeptide.
DE3751398D1 (de)	1995-08-17	Substrat-Peptide.
HU896448D0 (en)	1990-02-28	Process for the preparation of anticoagulant peptides
DE59109235D1 (de)	2002-05-29	Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DK0828004T3 (da)	2007-03-19	Proteindisulfidisomerase-gen afledt af stamme af methylotrof gær
EP1295943A4 (en)	2005-11-16	POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES
ATE301199T1 (de)	2005-08-15	Beta-primeverosidase gen
MX9709921A (es)	1998-08-30	Alfa-d-galactosidasas de glicina y phaseolus.